Pro 차트

Profound Medical Corp.

NasdaqCM: PROF · 실시간 가격 · USD
6.63
-0.04 (-0.60%)
종가 기준: Aug 14, 2026, 3:59 PM
6.63
+0.00%
애프터마켓: 7:34 PM

기업 설명

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.

Profound Medical Corp.
Profound Medical Corp. logo
국가Canada
IPO 일자2019년 10월 29일
산업Medical Devices
섹터Healthcare
직원 수162
CEODr. Arun Swarup Menawat MBA, Ph.D.

연락처

주소:
2400 Skymark Avenue
Mississauga, ON
Canada
웹사이트https://www.profoundmedical.com

주식 정보

티커PROF
거래소NasdaqCM
회계연도Jan '25 - Dec '25
보고 통화USD
CIK 코드0001628808
CUSIP 번호n/a
ISIN 번호n/a
고용주 식별번호n/a
SIC 코드n/a

주요 임원

이름직책
Dr. Arun Swarup Menawat MBA, Ph.D.Chairman of the Board & CEO
Dr. Mathieu Burtnyk Ph.D.President
Mr. Rashed DewanChief Financial Officer
Mr. Thomas Tamberrino MBAChief Commercial Officer
Mr. Stephen KilmerInvestor Relations
Mr. Matthew Sobczyk C.A., CPAAssistant Corporate Controller
Mr. Levant TinazSoftware Developer

최신 SEC 공시

SEC 공시가 없습니다.